Note that these findings provide evidence of cell- and context-specific changes in mitochondrial metabolism, and thus respiratory capacity, consequent with AMPK deficiency, and highlight the therapeutic potential for the treatment of obesity through increased whole-body energy expenditure. The gene discussed is PRKAA2; the disease is Obesity.